期刊文献+

尿毒清颗粒对CYP450与P-gp体外影响的初步研究

Effect of Niaoduqing granules on CYP450 and P-gp in vitro
下载PDF
导出
摘要 [目的]初步考察尿毒清颗粒(NDQ)对重组人细胞色素P450(CYP450)和P糖蛋白(P-gp)的体外影响。[方法]1)使用Promega P450-GloTM Screening System,通过荧光发光原理来检测NDQ组、抑制剂组对重组CYP450的IC5(0半数抑制浓度)值,比较NDQ组与抑制剂组IC50来评价NDQ对重组人CYP1A2、CYP2D6、CYP3A4、CYP2C19,CYP2C9的抑制作用。2)使用BD ATPase Assay Kit,通过发光法检测NDQ组、空白对照组P-gp三磷酸腺苷(ATP)酶活性,比较NDQ组、空白对照组ATP酶活性来评价NDQ是否为重组人P-gp的底物或抑制剂。[结果]1)NDQ组与抑制剂组IC50值(g/L)如下,CYP1A2:17.47、3.37×10-6;CYP3A4:33、4.181 3×10-5;CYP2C9:10.39、1.056×10-3;CYP2D6:13.98、2.245 9×10-6;CYP2C19:9.251、1.442×10-3。2)NDQ组的P-gp ATP酶的活性为16.39 nmol(/mg.min),空白对照组的ATP酶活性为4.72 nmol(/mg.min)。[结论]1)NDQ组IC50大于对应抑制剂组IC50,NDQ对重组人CYP1A2、CYP2D6、CYP3A4、CYP2C19、CYP2C9基本没有抑制作用。2)NDQ组ATP酶活性高于空白组并差异有统计学意义,NDQ可能为重组人P-gp的抑制剂或底物。 [Objective] To investigate the effects of Niaoduqing (NDQ) on recombined human cytochrome P450 (CYP450) and P glycoprotein(P-gp) in vitro primarily. [Methods] 1 )Using the Promega P450-GloTM Screening System and according to the fluorescence luminescence principle the ICso of NDQ group and inhibitor group to the ICs0 of recombined CYP450 was detected, comparing the ICso of NDQ group and inhibitor group the inhibitory effect of NDQ on recombined human CYP1A2, CYP2D6, CYP3A4, CYP2C 19, CYP2C9 was evaluated. 2)Using the BD ATPase Assay Kit and using luminescent technique the activity of P-gp ATPase in the NDQ group and blank control group was detected and through the comparison of the ATPase activity between NDQ and blank control group it was evaluated that whether NDQ was the substrates or inhibitors of recombined human P-gp or not. [Results] 1 )ICso value (g/L)in NDQ group and inhibitors group was as follows, CYP1A2:17.47, 3.37x10;CYP3A4:33, 4.181x10-5; CYP2C9 : 10.39, 1.056x10-3;CYP2D6:13.98, 2.245 9x10; CYP2C19 : 9.251, 1.442x10-3. 2)The vbg htyu 78 of P-gp A TPase activity in NDQ group was 16.39 nmo(mg.min). A TPase activity in the blank control group was 4.72 nmol/(mg, min). [Conclusion] 1 )IC5o in NDQ group is greater than the corresponding inhibitor group. NDQ basically has no inhibitory effect on recombined human CYPIA2, CYP2D6, CYP3A4, CYP2C19, CYP2C9. 2)The activity of ATPase in NDQ group is higher than blank group significantly, and NDQ possibly is the inhibitor or the substrates of the recombined human P-gp.
出处 《天津中医药》 CAS 2013年第7期427-430,共4页 Tianjin Journal of Traditional Chinese Medicine
基金 "重大新药创制"科技重大专项资助项目(2010ZX09502-004)
关键词 重组人细胞色素P450 P-糖蛋白三磷酸腺苷酶 半数抑制浓度 尿毒清颗粒 CYP450 P-gp ATPase IC5o Niaoduqing granule
  • 相关文献

参考文献7

二级参考文献32

  • 1关天增,孙顺霖,常洪志,张红瑞.半蒌贝蔹芨攻乌的实验研究[J].河南中医药学刊,1994,9(5):28-29. 被引量:16
  • 2李德淳.细胞色素P450酶系统在中医药研究中的应用[J].天津中医学院学报,1994,13(1):39-39. 被引量:11
  • 3金念祖,陈景衡.大鼠肝细胞色素P450含量测定的影响因素[J].中华预防医学杂志,1996,30(5):301-302. 被引量:6
  • 4丛铮 郑洪昌.小鼠肝匀浆细胞色素P-450含量测定方法的探讨[J].中药通报,1984,9(2):39-39.
  • 5SCHROEDER W ,Ghobrial L ,Gandhi P. Possible mechanisms of drug-induced aspirin and clopidogrel resistance [J].Journal of Thrombosis and Thrombolysis, 2006,22 ( 2 ) : 139- 150.
  • 6COZZA K L, ARMSTRONG S C, OESTER HELD J R. Drug interactions by medical specialty. In:Concise Guide to Drug Interaction Principles for Medical Practice: Cytochrome P450s, UGTs, P-Glycoproteins [M]. 2nd ed. Washington D C: American Psychiatric Pub, 2003,167-396.
  • 7ZEVIN S, BENOWITZ N L. Drug Interactions with Tobacco Smoking : An Update[J]. Clinical Pharmacokinetics, 1999,36 : 425-438.
  • 8DE LEON J, DIAZ F J, ROGERS T, et al. A pilot study of plasma caffeine concentrations in a US sample of smoker and nonsmoker volunteers [J]. Prog Neuropsychopharmaeol Biol Psychiatry, 2003,27 (1) : 165-171.
  • 9NGUYEN M ,CHUNG E P. Telithromycin :The first ketolide antimicrobial [J]. Clinical Therapeutics, 2005,27 (8) : 1144-1163.
  • 10SLAUGHTER R L, EDWARDS D J. Recent advances: the cytochrome P450 enzymes [J].Ann Pharmacother, 1995,29 : 619-624.

共引文献104

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部